We enable the potential of healthcare
Since the 1990's, Medipass has led the way in making technological innovation accessible for diagnostic imaging and cancer care with pioneering advancements in nuclear medicine and radiotherapy. With more than 30 years of experience in providing quality care and best practices for patients, we bring a wealth of expertise and a deep understanding of the challenges facing the healthcare ecosystem in Italy.
Medipass by the numbers
diagnostic and therapeutic procedures supported yearly through our integrated services contracts
active partnerships with hospitals across Italy in radiotherapy, nuclear medicine and diagnostic imaging
Diagnostic imaging outpatient centres under PPP management
proprietary outpatient centres
Our group
Medipass is part of the Ergéa Group, a pan-European provider of cancer care and diagnostic imaging services, built through the combination of distinct yet complementary experiences and business models, united by a common mission.
With a strong presence of physicians on both its Board of Directors and Executive Committee, the Ergéa Group places patients and healthcare professionals at the heart of its development strategy. The name Ergéa reflects a shared commitment across the Group to a patient-centred approach to healthcare.
Like much of Western medicine itself, the name Ergéa has Greek origins. In Greek, érgo means “work” and ygeía means “health”. Combined in the name Ergéa, these concepts evoke the idea of “working for health”, perfectly expressing our ambition: to deliver better healthcare where it has the greatest impact — close to the patient. This is where healthcare systems can make a meaningful difference in people’s lives.
Our journey
Our story began in the 1990s, when we pioneered the development and management of clinical services that facilitated the adoption and use of magnetic resonance imaging in Italy.
Over time, we have evolved our service model, becoming a partner for technological, clinical and organisational innovation in healthcare. We have progressively expanded our expertise from diagnostic imaging to cancer diagnosis and treatment, supported by integrated healthcare services.
Today, we support public and private healthcare providers in the development and management of complex services through flexible models and innovative solutions based on long-term partnerships, helping to ensure the broad dissemination of best practices for the benefit of patients.
Here are the most recent milestones in our journey.
The Ecomedica Specialistica joint venture is established, located in the same building as Ecomedica Spa, with the aim of providing an even more comprehensive range of healthcare services and better meeting patient needs through additional specialized and diagnostic services.
A collaboration is launched with the IRCCS Policlinico San Donato, part of the San Donato Group, to strengthen the Radiotherapy Department.
Medipass expands its service portfolio through the acquisition of IML, a company specialising in mobile diagnostic solutions, and Servitech, a provider of high-complexity services in the cardiovascular and interventional radiology fields, introducing new service models complementary to its existing activities.
At the same time, Medipass strengthens its territorial presence through the acquisition of the La Fenice Centres in the Marche region, a well-established provider of outpatient and rehabilitation services, as well as diagnostic centres in Bologna and Ferrara.
2023
Medipass acquires Poliambulatorio Etruria, an outpatient centre that provides diagnostic imaging and specialised medical care to public and private patients in Marzabotto.
Medipass transforms the Nuclear Medicine department at Miulli Hospital in Apulia by managing a full PET-CT clinical service.
Medipass introduces MRI-Linac technology in Italy and Europe in partnership with University Hospital Gemelli ART (Advanced Radiation Therapy).
Presence across the territory
We have several operations in Bologna, including our Italian headquarters.
- Our outpatient centres Medica Polambulatorio in San Giovanni in Persiceto (Bo) and Centro Medico Poliambulatorio in Anzola dell’Emilia (Bo), enable high-quality diagnostic imaging and specialised medical care to approximately 100,000 residents living in the Pianure area.
- As part of a PPP contract with Bologna ASL (Local Healthcare Authority), we manage six outpatient diagnostic imaging centres in Casalecchio di Reno (BO), Crevalcore (BO), Molinella (BO), Pieve di Cento (BO) and San Pietro in Casale (BO).
- Since planning, implementing and installing the diagnostic imaging department at the privately accredited Hospital Villa Laura almost ten years ago, we have provided ongoing clinical services to the hospital.
- We have a long history of collaboration with the private hospital Casa di Cura Madre Fortunata Toniolo, with a contract renewed in 2023 for a significant technical and organisational innovation plan of their Diagnostic Imaging department through an innovative partnership scheme.
- Our outpatient centre Poliambulatorio Etruria provides diagnostic imaging and specialised medical care, integrating the healthcare offering in an under-served area.
-
Through the acquisition of the diagnostic centre in Bologna, Medipass further strengthens its presence in the area.
The facility is equipped with open and high-field MRI scanners, high-definition CT technology, digital mammography and digital radiography. It serves as a key reference point for the local community, contributing to the expansion of diagnostic services and improved access to care.
The acquisition of the diagnostic centre in Ferrara marks the Group’s entry into a new territory, expanding its geographical coverage in the Emilia-Romagna region.
The centre is equipped with advanced technologies, including magnetic resonance imaging (featuring a 3 Tesla MRI scanner), high-definition CT technology and radiology services. It contributes to strengthening the Group’s presence in community-based diagnostic services.
- Since launching our successful partnership with the University Hospital Agostino Gemelli almost 20 years ago, we have implemented the most advanced technological innovations through turnkey projects for the Nuclear Medicine and Radiotherapy departments. We continue to provide various clinical services to the hospital, supporting the facility in delivering high-quality patient care, sophisticated research and teaching.
- We established the Nuclear Medicine department at University Hospital Campus Bio-Medico in 2021, which we have managed since then.
-
Through the acquisition of Servitech, Medipass extends its expertise in the management of high-complexity services in the cardiovascular and interventional radiology fields.
Servitech supports healthcare providers in the operational management of specialised activities, including the supply and management of consumables, as well as the optimisation of clinical and logistical processes.
These activities contribute to improving operational efficiency and service sustainability, reinforcing the Group’s role as an integrated partner for healthcare providers.
The collaboration with the IRCCS Policlinico San Donato, part of the San Donato Group, was established with the aim of revitalizing and strengthening the activities of the Radiotherapy Unit through:
- Technological renewal, including the supply and management of a state-of-the-art linear accelerator, the upgrade of dedicated information systems, and advanced ancillary equipment.
- Organizational optimization, through the contribution of specialized medical personnel, medical physicists, healthcare technicians, nursing staff, and administrative personnel.
These efforts aim to ensure the availability of the most advanced treatment techniques for an increasing number of patients in the province of Milan and the Lombardy region.
Through the acquisition of IML, Medipass expands its service offering by introducing mobile diagnostic solutions.
IML specialises in the provision and management of mobile MRI, Mammography, Cath Lab, CT and PET-CT units, enabling advanced technologies to be delivered directly to local communities or ensuring operational continuity during refurbishment works and equipment replacement projects.
This model allows healthcare providers to access flexible and rapidly deployable services, improving access to care and optimising diagnostic capacity management.
We operate two outpatient centers: Clinica del Tendine and Fisiomedic (www.centrofisiomedic.it). Both centers specialize in physiotherapy and rehabilitation and are equipped with specialist clinics and imaging diagnostic services, some of which are also covered by the regional health service.
Through the acquisition of the La Fenice Centres, Medipass has integrated a well-established healthcare provider in the Marche region.
The two outpatient centres offer a broad range of services, with a particular focus on diagnostic imaging and specialist outpatient care, complemented by physiotherapy and rehabilitation services, a blood collection point, a specialist ophthalmology centre and a dental clinic.
The facilities are distinguished by their multidisciplinary approach and their focus on quality of care and patient experience.
We have provided clinical services for the Department of Radiotherapy at the private accredited hospital Mater Olbia since managing its planning and turnkey installation in 2021, establishing one of Italy's most advanced radiotherapy units, featuring innovative technologies allowing adaptive radiotherapy to patients in Sardinia.
Our collaboration with General Hospital Ospedale dell’Angelo began 25 years ago with MRI and PET-CT technology. We continue to support the departments of Radiology and Neuroradiology through an MES contract, enabling the functioning of the diagnostic equipment and ensuring the availability of consumables.
We planned and implemented the Radiotherapy department at the private hospital Gemelli Molise in 2019, and we continue to support the hospital through our integrated clinical services offering.
At the private General Hospital F. Miulli, we planned and implemented the Radiotherapy department in 2019 and the PET-CT department in 2022. We continue to support the hospital through our integrated clinical services offering.
We operate two outpatient and diagnostic centers:
- Ecomedica Poliambulatorio, established in 2017, offers imaging diagnostics, radiotherapy, endoscopy, and other high-quality clinical specialties for both public and private patients.
- Ecomedica Specialistica, a center dedicated to providing additional specialized and diagnostic services for self-paying and insured patients.
Bologna
FerraraFerrara
RomeRome
MilanMilan
CesenaCesena
Civitanova Marche/Porto Sant'ElpidioCivitanova Marche/Porto Sant'Elpidio
Olbia (Sassari)Olbia
Venezia Mestre (Venice)Venezia Mestre (Venezia)
CampobassoCampobasso
Acquaviva delle Fonti (Bari)Acquaviva delle Fonti (Bari)
Empoli (Florence)Empoli (Firenze)
Our team
We wouldn’t be able to realise our vision to enable the potential of healthcare without the experience and dedication of our talented team. They bring their expertise and passion for improving the patient experience and medical outcomes to each and every partnership, every single day.
Meet the outstanding team leaders working together with their teams to ensure service excellence.
As the CEO of Medipass S.p.A, Michele Corti draws on his extensive experience in both consulting and business development to drive the success of the organisation. He defines the affiliate’s strategic direction, oversees acquisition initiatives and navigates complex negotiations to drive business expansion in Italy with a focus on outpatient centres and clinical services. Michele is also a member of Ergéa Group’s Executive Committee.
Michele joined Medipass in 2011 to lead the business development team and was appointed CEO in 2022.
A Medipass founding partner and pioneer in private-public partnerships (PPP), Flavio Vinci is responsible for overseeing the clinical aspects of Medipass operations, from our outpatient clinics to integrated management of high-tech departments within public and private hospitals. He has a proven track record of delivering exceptional results due to his commitment to excellence, focus on collaboration and unwavering dedication to improving medical outcomes through health technology and innovations. Flavio is also a member of Ergéa Group’s Executive Committee.
Before founding Medipass, Flavio worked in sales and marketing positions in multinational OEM companies.
As the leader of our project development team, Roberto Saggini is responsible for planning new, multidisciplinary transformation projects for private and public hospitals throughout Italy. With his extensive project management skills, he has a proven track record of delivering quality-focused and effective solutions to complex scenarios, ensuring that stakeholder requirements are met.
Before joining Medipass in 2007, Roberto gained significant experience in project management, sales and marketing positions at various international medical companies.
Manuela Tozzola has been working at Medipass since 2010 when she joined the company as Administration Manager. Since 2021, Manuela has been responsible for supervising the operations at our outpatient and diagnostic imaging centres.
As the sales team manager, Alberto Rossi is responsible for promoting our core services and identifying new project opportunities with private and public hospitals throughout all regions of Italy. He ensures that our sales team operates effectively and efficiently to achieve our business objectives.
Before joining Medipass in 2016, Alberto gained significant experience in business management and sales at various international diagnostic imaging equipment manufacturers.
Emiliano Vandelli is responsible for the administrative management and development of human resources, focusing on the recruitment, retention and professional growth of all personnel, whether they work at our clients’ healthcare facilities or our clinics and offices. He is also responsible for legal affairs and internal privacy.
Before joining Medipass in 2020, Emiliano had 20 years of experience in human resource management in the healthcare sector.
Francesco Rizzoli, with his dual role of Chief Financial Officer and Head of Business Development, is in charge of managing the AFC (administration, finance and control) and the BD office (active in the analysis and evaluation of new opportunities, such as turnkey projects for Integrative Clinical Services, M&A operations and other business development initiatives), fostering full organisational and functional synergy between the two areas.
Before joining Medipass in 2018, Francesco worked across various sectors, including facility management (strategic planning and management control department), private equity (with time spent in Shanghai) and corporate finance (M&A and business planning).
Matteo Stocco is responsible for cash management, including managing relationships with local and international banks and financial institutions. With a wealth of experience in financial planning, he also oversees the management of the company’s debt and net financial position, serving as the primary point of contact to ensure that both local and group financial policies are in place.
Before joining Medipass in 2021, Matteo worked as a treasury specialist and analyst in various companies.
Mara Giorgia Migliazza is responsible for ensuring that our organisation adheres to all relevant legislation and codes of practice. She takes the lead in promoting awareness and driving a proactive approach to matters relating to quality, environmental health and safety within our company.
Before joining Medipass in 2009, Mara worked in different roles at GE Healthcare.
Michael Garollo oversees the development, implementation and maintenance of our company’s information and communications strategy and systems. He also ensures that appropriate data security measures are introduced and maintained to support our business objectives.
Before joining Medipass in 2019, Michael worked as a project manager and sales specialist for a major software house, developing information systems for the public and private healthcare sectors.
Martina Eleonora Caldarelli is responsible for the consolidated financial statements of Ergea Group Italia.
She supervises all compliance activities of the group, is responsible for the statutory process of all group entities and oversees all tax and administrative matters. Before joining Medipass in 2021, Martina spent 6 years in the Deloitte audit team, performing audit work in the preparation of stand-alone and consolidated financial statements, of listed and unlisted companies, according to national (OIC) or international (IFRS)
accounting standards.
Giovanni Balatroni is responsible for conducting periodic economic and financial analyses, including pricing and reporting. He also manages and supervises the business planning process, serving as the primary point of contact with both local and group management.
Before joining Medipass in 2007, Giovanni gained experience in highly reputable international auditing companies.
Governance policies
Medipass recognises the importance of corporate social responsibilities, and pursues its objectives while establishing and maintaining a relationship of mutual trust between stakeholders, contractors and the relevant community, in full respect of the law and of the principles of honesty, impartiality and transparency. Employees and all those involved in Medipass are required to abide by the rules and regulations established in the company’s Code of Conduct.
The majority owner of Ergéa Group is DWS, one of the world’s leading asset and infrastructure managers, on behalf of one of its European infrastructure funds.
Strong support from our shareholders allows us to focus on long-term growth and pursue new opportunities whilst providing a return on stakeholder investment.